We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
10351
Permian Basin Royalty Trust
PBT
$1.52B
$194K ﹤0.01%
11,885
-23,014
-66% -$400K
RMAX icon
10352
RE/MAX Holdings
RMAX
$268M
$194K ﹤0.01%
+10,246
New +$243K
NEUE
10353
CALL
DELISTED
NeueHealth
NEUE
$194K ﹤0.01%
2,309
-196
-8% -$26K
ARVL
10354
PUT
DELISTED
Arrival Ordinary Shares
ARVL
$194K ﹤0.01%
4,806
+302
+7% +$19.9K
CWAN
10355
PUT
DELISTED
Clearwater Analytics
CWAN
$193K ﹤0.01%
11,500
-10,000
-47% -$146K
DOLE icon
10356
CALL
Dole
DOLE
$1.26B
$193K ﹤0.01%
26,400
-21,000
-44% -$187K
MORT icon
10357
CALL
VanEck Mortgage REIT Income ETF
MORT
$375M
$193K ﹤0.01%
17,500
-9,700
-36% -$139K
UFO icon
10358
Procure Space ETF
UFO
$634M
$193K ﹤0.01%
10,779
-8,930
-45% -$184K
COOLU
10359
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
$193K ﹤0.01%
19,415
-210
-1% -$2.08K
CD
10360
PUT
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$193K ﹤0.01%
23,900
+2,500
+12% +$19.3K
ADCT icon
10361
ADC Therapeutics
ADCT
$129M
$192K ﹤0.01%
+39,791
New +$288K
ALLO icon
10362
PUT
Allogene Therapeutics
ALLO
$708M
$192K ﹤0.01%
+17,800
New +$242K
FBRT
10363
CALL
Franklin BSP Realty Trust
FBRT
$670M
$192K ﹤0.01%
17,800
+2,500
+16% +$34.4K
GETY icon
10364
Getty Images
GETY
$129M
$192K ﹤0.01%
+28,298
New +$534K
IRWD icon
10365
Ironwood Pharmaceuticals
IRWD
$712M
$192K ﹤0.01%
+18,519
New +$210K
ITOS
10366
CALL
DELISTED
iTeos Therapeutics
ITOS
$192K ﹤0.01%
10,100
-15,200
-60% -$350K
TRHC
10367
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$192K ﹤0.01%
39,833
-276,888
-87% -$1.19M
KZR
10368
PUT
DELISTED
Kezar Life Sciences
KZR
$191K ﹤0.01%
2,220
-11,640
-84% -$1.13M
WW
10369
PUT
DELISTED
WW International
WW
$191K ﹤0.01%
48,700
-32,000
-40% -$194K
EMBK
10370
PUT
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$191K ﹤0.01%
+25,640
New +$255K
CMBM
10371
PUT
DELISTED
Cambium Networks
CMBM
$190K ﹤0.01%
11,200
+1,000
+10% +$17.9K
FOR icon
10372
Forestar Group
FOR
$1.5B
$190K ﹤0.01%
17,020
-42,085
-71% -$557K
RITM icon
10373
Rithm Capital
RITM
$5.79B
$190K ﹤0.01%
26,033
+5,871
+29% +$55.9K
VFF icon
10374
CALL
Village Farms International
VFF
$309M
$190K ﹤0.01%
99,700
-37,100
-27% -$99.6K
VKTX icon
10375
CALL
Viking Therapeutics
VKTX
$3.87B
$190K ﹤0.01%
69,800
-1,600
-2% -$5.24K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.